共 44 条
- [43] Alemtuzumab (anti-CD52 mAb) administration induces a significant expansion of T-regulatory cells, increased TGF beta IL-10 and IL-4 and decreased IFN-gamma and IL-17 production in the ex-vivo separated CD4+cells from treated patients with relapsing remitting multiple slerosis MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S188 - S188